Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT06287918
Title A First-in-human Study of 3HP-2827 in Patients With Unresectable or Metastatic Solid Tumors With FGFR2 Alterations
Recruitment Not yet recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors 3H (Suzhou) Pharmaceuticals Co., Ltd.
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST